GS 101: Clinical Trials

1 trial of GS 101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow GS 101: new trials by email Literature Review of GS 101 trials Research Report on GS 101

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
aganirsen - Ischaemic Central Retinal Vein Occlusion, Neovascular Glaucoma
Phase 2 / Phase 3UnknownGene Signal SAS3332017-01-012016-10-31

Conditions studied

Glaucoma, Neovascular (1)

Sponsors

Gene Signal SAS (1)

Results publications

PMID 28302155

NIH funding

2014 (1)